Pterostilbene: Resveratrol’s More Bioavailable Cousin, With a Much Thinner Human Trial Record
Pterostilbene is often marketed as “the better resveratrol.” The bioavailability claim behind that pitch is real and substantial. What gets less airtime: pterostilbene’s actual human clinical trial base is far thinner than resveratrol’s, and the one dedicated human safety trial found a dose-dependent wrinkle worth knowing about.
The Real Bioavailability Advantage
Pterostilbene is structurally similar to resveratrol, differing by two methoxy groups in place of resveratrol’s hydroxyl groups. This makes it more lipophilic (fat-soluble), which is a real, measurable pharmacokinetic advantage: roughly 80% oral bioavailability in animal models, compared to about 20% for resveratrol, and a substantially longer half-life (roughly 105 minutes versus 14 minutes for resveratrol). This part of the “better resveratrol” pitch is genuinely accurate.
The Human Safety Trial
This is one of the few dedicated human trials on pterostilbene specifically, and it points to a real, dose-dependent consideration: more isn’t automatically better or safer here, and the higher of the two tested doses showed effects worth being cautious about.
The Honest Verdict
Multiple independent reviews of the pterostilbene literature converge on the same conclusion: the bioavailability advantage is real, but human clinical evidence for pterostilbene specifically is much more limited than for resveratrol, which has decades of human trial data across cardiovascular health, metabolic syndrome, and other outcomes, funded in part by major research institutions. Pterostilbene’s case is, as one independent review put it, “mechanistically compelling but clinically unproven.”
The NR + Pterostilbene Combination
We reviewed Elysium Health Basis, which combines nicotinamide riboside (NR) with 50mg of pterostilbene — matching the lower, apparently safer dose from the Riche trial. Worth knowing: pairing NR with pterostilbene is a common approach in this product category, but the rationale for combining them specifically is mechanistic (both are studied separately for cellular aging pathways), not based on a clinical trial testing the combination itself.
Safety Considerations
- May inhibit CYP2B6 and CYP2C9 enzymes, potentially affecting drugs like warfarin, phenytoin, or certain NSAIDs
- Has mild estrogenic activity in some research — discuss with a doctor if you’re on hormone therapy or oral contraceptives
- The 100mg/day dose showed cholesterol and blood pressure changes in the primary human safety trial; the 50mg dose did not
- Long-term human safety data beyond a few months is essentially absent
This isn’t medical advice — talk to a healthcare provider before starting any supplement, especially if you take medication or have a hormone-sensitive condition.
FAQ
Is pterostilbene actually better than resveratrol?
It’s better absorbed per milligram, which is real and measurable. But resveratrol has a far larger human clinical trial base. “Better” depends on whether you’re weighing pharmacokinetics or the depth of human evidence.
Is 100mg safer or more effective than 50mg?
The only dedicated human safety trial found cholesterol and blood pressure changes at 100mg/day that weren’t seen at 50mg/day. Higher isn’t necessarily better here.
Does combining it with NAD+ precursors like NR make sense?
The rationale is mechanistic — both are studied for cellular aging pathways separately — but no clinical trial has tested the specific combination for its own outcomes.
Do I need a prescription?
No. Pterostilbene is available as an over-the-counter dietary supplement.
See how this fits into our full product score
Read Our Elysium Health Basis ReviewLast reviewed: September 2026 · Read our full rating methodology.